9th Circ. Says FDA Has Dibs On Copycat Drug Suits
A Ninth Circuit panel on Tuesday affirmed a California judge's decision to toss a pharmaceutical manufacturer's claims that a compounding pharmacy unlawfully produced copies of its U.S. Food and Drug Administration-approved...To view the full article, register now.
Already a subscriber? Click here to view full article